-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $49 Price Target

Benzinga·05/07/2025 11:12:05
Listen to the news
Needham analyst Ami Fadia reiterates Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Buy and maintains $49 price target.